nCounter® Immune Exhaustion Panel

Helping Your Research

Uncover the mechanisms behind T cell, B cell, and NK cell exhaustion in diverse contexts, including cancer and infectious disease, with a 785 gene panel that gets you results in less than 24 hours and is compatible with a broad range of sample types. Characterize immune status, develop signatures for assessing the exhausted state, and identify novel therapeutic targets to prevent or reverse exhaustion.

How It Works

Feature Details
Viral Identification
Tumor Inflammation Signature
Feature Details
  • Directly profile 785 genes across 47 pathways involved in immune exhaustion:
    • Immune Activation
    • Immune Suppression
    • Immune Status
    • Immune Checkpoints
    • Epigenetics
    • Metabolism & Microenvironment
  • Understand the mechanisms of exhaustion in T cells, B cells, NK cells, CAR-T cells and other adoptive immune cells
  • Discover novel therapeutic targets for preventing or reversing immune exhaustion
  • Determine the extent of a peripherally suppressed, adaptive immune response to cancer with the 18-gene Tumor Inflammation Signature (TIS)
  • Quantify the presence and relative abundance of 14 different immune cell types
Viral Identification

Chronic infections caused by viruses and other pathogens can induce immune exhaustion. The Human Immune Exhaustion Panel includes probes for Epstein-Barr virus (EBV) and Cytomegalovirus (CMV), and the Mouse Immune Exhaustion Panel includes probes for Lymphocytic Choriomeningitis (LCMV). The panel can be supplemented with up to 55 genes of your choice with a Panel Plus spike-in for studying exhaustion in the context of different types of infectious disease.

Tumor Inflammation Signature

The 18-gene Tumor Inflammation Signature (TIS) is included in the panel gene list and measures activity known to be associated with PD-1/PD-L1 inhibitors. Customers have the option to purchase a standalone TIS report with the Immune Exhaustion Panel.

  • Includes four axes of biology that characterize a peripherally suppressed, adaptive immune response, including:
    • Antigen presenting cells
    • T cell/NK cell presence
    • IFNγ biology
    • T cell exhaustion
  • Tissue-of-origin agnostic (Pan-Cancer)
  • Potential surrogate for PD-L1 and mutational load in a research setting

Publications

View All Publications

The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma.

Background: Tertiary lymphoid structures (TLSs) play key roles in tumour adaptive immunity. However, the prognostic value and molecular properties of TLSs in oesophageal squamous cell carcinoma (ESCC) patients have not been studied.

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance.

While great strides have been made in the treatment of advanced renal cell carcinoma (RCC) with the emergence of immune checkpoint inhibitors (ICIs) and VEGFR-targeting drugs, sizable proportions of patients still do not respond to upfront therapy and long-term responses only occur in a minority of patients. There is therefore a great need for the development of better predictors of response and an increased understanding of mechanisms of resistance to these therapies.

The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis.

Brain metastases (BrMs) are a common occurrence in lung cancer with a dismal outcome. To understand the mechanism of metastasis to inform prognosis and treatment, here we analyze primary and metastasized tumor specimens from 44 non-small cell lung cancer patients by spatial RNA sequencing, affording a whole transcriptome map of metastasis resolved with morphological markers for the tumor core, tumor immune microenvironment (TIME), and tumor brain microenvironment (TBME).

Product Information

Resources
Specifications
Core Themes and Annotations
Immune Checkpoint Coverage
Immune Cell Profiling Feature
Catalog Information
Specifications
Core Themes and Annotations

The nCounter Immune Exhaustion Panel enables researchers to explore the mechanisms behind T cell, B cell, and NK cell exhaustion in diverse contexts, including cancer and infectious disease.

Immune Checkpoint Coverage

The Immune Exhaustion Panel provides comprehensive coverage of the most relevant immune checkpoints that can potentially be used to modulate the dynamics of the immune response.

Immune Cell Profiling Feature
Catalog Information

Request a Quote

Contact our helpful experts and we’ll be in touch soon.